{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260529392296/en/BeOne-Medicines-Establishes-Standard-for-Long-Term-Disease-Control-in-CLL-with-BRUKINSA-78-Month-Data-at-ASCO-2026", "message": "News view counter 766450 successfully enlarged"}